Stock listing
BOATS:PMVP PMV Pharmaceuticals, Inc. Stock
US listing (BOATS) of PMV Pharmaceuticals, Inc. · home listing NASDAQ:PMVP
Follow PMV Pharmaceuticals, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:PMVP
$1.37 USD +0.06 (+4.6%)
Close on Nov 2, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:PMVP
- Day range
- $1.31 – $1.40 USDNov 2, 2026
- Volume
- 440,424 sharesNov 2, 2026
- Market cap
- $103.5M USDAt the close on Nov 2, 2026 · price × 75.51M shares outstanding
- 52-week range
- $1.02 – $1.91 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $968,627 USDMedian day 410,200 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:PMVP · Home | $1.37 USD | +0.06 (+4.6%) | 440,424 | $1.31 | $1.40 | $1.31 | $1.31 | Close on Nov 2, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:PMVP · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.37 | +0.06 | +4.6% | $1.31 | $1.40 | $1.31 | 440,424 | |
| $1.31 | -0.04 | -3.0% | $1.33 | $1.331 | $1.21 | 1,212,844 | |
| $1.35 | -0.03 | -2.2% | $1.39 | $1.39 | $1.33 | 238,113 | |
| $1.38 | +0.13 | +10.4% | $1.25 | $1.39 | $1.22 | 348,869 | |
| $1.25 | +0.12 | +10.6% | $1.17 | $1.28 | $1.155 | 374,669 | |
| $1.13 | -0.14 | -11.0% | $1.26 | $1.285 | $1.10 | 648,479 | |
| $1.27 | -0.035 | -2.7% | $1.30 | $1.33 | $1.255 | 171,000 | |
| $1.305 | -0.055 | -4.0% | $1.36 | $1.37 | $1.30 | 128,600 | |
| $1.36 | -0.03 | -2.2% | $1.37 | $1.41 | $1.35 | 236,600 | |
| $1.39 | +0.135 | +10.8% | $1.26 | $1.41 | $1.26 | 347,600 | |
| $1.255 | +0.045 | +3.7% | $1.21 | $1.29 | $1.21 | 196,000 | |
| $1.21 | -0.08 | -6.2% | $1.28 | $1.30 | $1.20 | 357,600 | |
| $1.29 | +0.05 | +4.0% | $1.26 | $1.33 | $1.24 | 376,600 | |
| $1.24 | -0.11 | -8.1% | $1.33 | $1.37 | $1.23 | 525,800 | |
| $1.35 | -0.06 | -4.3% | $1.40 | $1.466 | $1.315 | 541,300 | |
| $1.41 | -0.11 | -7.2% | $1.55 | $1.55 | $1.40 | 398,600 | |
| $1.52 | +0.03 | +2.0% | $1.49 | $1.61 | $1.48 | 891,700 | |
| $1.49 | -0.01 | -0.7% | $1.51 | $1.54 | $1.46 | 461,400 | |
| $1.50 | -0.11 | -6.8% | $1.59 | $1.60 | $1.48 | 607,400 | |
| $1.61 | -0.17 | -9.6% | $1.78 | $1.81 | $1.591 | 616,100 | |
| $1.78 | -0.01 | -0.6% | $1.80 | $1.84 | $1.70 | 1,185,500 | |
| $1.79 | +0.04 | +2.3% | $1.75 | $1.87 | $1.68 | 3,735,800 | |
| $1.75 | +0.08 | +4.8% | $1.68 | $1.91 | $1.63 | 1,647,200 | |
| $1.67 | +0.24 | +16.8% | $1.44 | $1.725 | $1.44 | 3,124,700 | |
| $1.43 | +0.07 | +5.1% | $1.37 | $1.45 | $1.36 | 550,900 | |
| $1.36 | +0.03 | +2.3% | $1.34 | $1.39 | $1.30 | 336,100 | |
| $1.33 | -0.005 | -0.4% | $1.32 | $1.38 | $1.29 | 271,200 | |
| $1.335 | -0.035 | -2.6% | $1.36 | $1.40 | $1.28 | 486,300 | |
| $1.37 | -0.14 | -9.3% | $1.51 | $1.52 | $1.365 | 570,700 | |
| $1.51 | +0.035 | +2.4% | $1.47 | $1.525 | $1.46 | 316,900 | |
| $1.475 | -0.025 | -1.7% | $1.50 | $1.51 | $1.445 | 330,000 | |
| $1.50 | +0.04 | +2.7% | $1.46 | $1.52 | $1.43 | 1,184,900 | |
| $1.46 | +0.03 | +2.1% | $1.43 | $1.50 | $1.42 | 430,800 | |
| $1.43 | +0.07 | +5.1% | $1.37 | $1.51 | $1.37 | 1,021,700 | |
| $1.36 | -0.10 | -6.8% | $1.45 | $1.45 | $1.35 | 705,400 | |
| $1.46 | +0.06 | +4.3% | $1.42 | $1.495 | $1.38 | 1,109,800 | |
| $1.40 | -0.04 | -2.8% | $1.45 | $1.505 | $1.40 | 538,600 | |
| $1.44 | +0.065 | +4.7% | $1.34 | $1.45 | $1.34 | 673,600 | |
| $1.375 | +0.035 | +2.6% | $1.34 | $1.39 | $1.34 | 419,100 | |
| $1.34 | +0.05 | +3.9% | $1.31 | $1.375 | $1.29 | 1,163,500 | |
| $1.29 | +0.05 | +4.0% | $1.24 | $1.35 | $1.24 | 530,000 | |
| $1.24 | -0.02 | -1.6% | $1.26 | $1.289 | $1.199 | 576,300 | |
| $1.26 | -0.03 | -2.3% | $1.26 | $1.29 | $1.242 | 704,300 | |
| $1.29 | +0.08 | +6.6% | $1.15 | $1.31 | $1.115 | 6,823,800 | |
| $1.21 | -0.01 | -0.8% | $1.24 | $1.24 | $1.21 | 1,115,500 | |
| $1.22 | -0.02 | -1.6% | $1.25 | $1.25 | $1.215 | 90,900 | |
| $1.24 | -0.07 | -5.3% | $1.30 | $1.31 | $1.22 | 197,500 | |
| $1.31 | +0.005 | +0.4% | $1.30 | $1.32 | $1.295 | 94,500 | |
| $1.305 | 0.00 | 0.0% | $1.31 | $1.32 | $1.29 | 211,700 | |
| $1.305 | -0.025 | -1.9% | $1.34 | $1.36 | $1.30 | 168,300 | |
| $1.33 | +0.03 | +2.3% | $1.32 | $1.34 | $1.30 | 131,300 | |
| $1.30 | +0.02 | +1.6% | $1.29 | $1.35 | $1.27 | 458,100 | |
| $1.28 | +0.04 | +3.2% | $1.26 | $1.28 | $1.24 | 183,700 | |
| $1.24 | -0.01 | -0.8% | $1.22 | $1.27 | $1.22 | 104,800 | |
| $1.25 | -0.01 | -0.8% | $1.26 | $1.28 | $1.245 | 241,600 | |
| $1.26 | +0.045 | +3.7% | $1.23 | $1.285 | $1.215 | 189,800 | |
| $1.215 | -0.045 | -3.6% | $1.29 | $1.29 | $1.21 | 81,200 | |
| $1.26 | -0.04 | -3.1% | $1.30 | $1.33 | $1.25 | 208,300 | |
| $1.30 | +0.07 | +5.7% | $1.22 | $1.325 | $1.22 | 314,869 | |
| $1.23 | +0.04 | +3.4% | $1.19 | $1.24 | $1.16 | 134,940 | |
| $1.19 | +0.01 | +0.8% | $1.18 | $1.21 | $1.16 | 118,400 | |
| $1.18 | +0.01 | +0.9% | $1.17 | $1.20 | $1.15 | 124,200 | |
| $1.17 | 0.00 | 0.0% | $1.18 | $1.19 | $1.16 | 137,600 | |
| $1.17 | +0.05 | +4.5% | $1.14 | $1.18 | $1.10 | 410,200 | |
| $1.12 | +0.01 | +0.9% | $1.11 | $1.165 | $1.04 | 2,105,500 |
- Ticker
- BOATS:PMVP
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Oct 5, 2026
PMV Pharmaceuticals Appoints Matt Eckler, Ph.D., to Board of Directors
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 27 slides
Latest news
PMV Pharmaceuticals Appoints Matt Eckler, Ph.D., to Board of Directors
Oct 5, 2026
Closed $1.78 (-0.6%) on Oct 5, 2026
PMV Pharmaceuticals Appoints Philip Herman as Chief Commercial Officer
Sep 8, 2026
Closed $1.34 (+3.9%) on Sep 8, 2026
PMV Pharma Announces Pricing of Oversubscribed $50 Million Public Offering of Securities
Aug 31, 2026
Closed $1.29 (+6.6%) on Sep 1, 2026
PMV Pharma Announces Proposed Public Offering of Securities
Aug 31, 2026
Closed $1.29 (+6.6%) on Sep 1, 2026
PMV Pharmaceuticals Announces Updated Promising Rezatapopt Monotherapy Interim Ovarian Cancer Data From PYNNACLE Phase 2 Pivotal Trial
Aug 31, 2026
Closed $1.29 (+6.6%) on Sep 1, 2026
PMV Pharmaceuticals Reports Second Quarter 2026 Financial Results and Corporate Highlights
Aug 14, 2026
Closed $1.26 (+3.7%) on Aug 14, 2026
PMV Pharmaceuticals Reports First Quarter 2026 Financial Results and Corporate Highlights
May 12, 2026
Closed $1.42 (+2.2%) on May 12, 2026
PMV Pharmaceuticals Announces Board Chair Transition
Apr 22, 2026
Closed $1.48 (+1.4%) on Apr 22, 2026
PMV Pharmaceuticals Reports Full Year 2025 Financial Results and Corporate Highlights
Mar 6, 2026
Closed $1.64 (+7.2%) on Mar 6, 2026
Financings
Public offering of common stock and accompanying warrants, or pre-funded warrants and accompanying warrants
Sep 1, 2026
Announced: about US$50.8M · US$1.21 a share · 1 warrant at US$1.21 for 60 months · TD Cowen
Dealers: TD Cowen (lead)
Decks
Investor Presentation (September 2026)
Investor deck · 27 slides · September 2026
Investor Presentation (September 2025)
Investor deck · 43 slides · Sep 10, 2025
Technical Presentation (October 2023)
Technical · 25 slides · Oct 12, 2023
ASCO 2022 PC14586 Investor Event
Conference · 32 slides · Jun 8, 2022
PMV Pharmaceuticals, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 11 in the last 12 months · 54 in all · newest Oct 5, 2026 · oldest 2020
- Decks
- 5 decks · latest September 2026
Where PMV Pharmaceuticals, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:PMVP · Home listing | NASDAQ | United States | USD |
| BOATS:PMVP · This page | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about PMV Pharmaceuticals, Inc.